Genpact's 24% ATS Surge Is the Real Story in Q2-But the Multiple Won't Move Without More Proof

ATS growth is changing the mix

The number that matters is 24.1%. Genpact's advanced technology revenue grew at that pace in the quarter, versus 7.1% for total revenue and 13.6% for adjusted EPS ATS revenue up 24.1% net revenues up 7.1% adjusted diluted EPS up 13.6%. That spread is the hook. This was not just another decent quarter; it suggests the mix inside the business is shifting.

Why mix matters more than a single strong quarter

ATS now represents 27% of total net revenue, and management expects ATS revenue to grow at least 25% for the full year 27% of total net revenues ATS revenue to grow at least 25% for the full year. In practical terms, more of Genpact's work is moving toward automation, analytics, and outcomes, and less depends on adding bodies to a desk. When more revenue comes from higher-value work, the business can become both faster and richer over time.

That is why the multiple could eventually move. A better mix does not just lift growth; it can improve the quality of that growth and the cash generated per unit of revenue.

Why investors still want more proof

This does not look like a one-quarter fluke. Genpact just posted its 13th straight quarter of gross margin expansion 13th consecutive quarter of year-over-year gross margin expansion, and management tied the result to strong client demand and disciplined execution. Bears can still argue one quarter is not enough, and that is fair. For now, the cleaner mix looks real, but the market likely wants another quarter or two of confirmation before paying up.

The booking momentum looks operational, not theoretical

What bulls care about now is not the quarter itself, but whether the pipeline can keep feeding the business.

Bookings and backlog are the fuel for the next few years

On the call, management pointed to record bookings, increasing backlog, and continued pipeline growth. That matters because bookings are the fuel tank for future revenue and margin durability. If Genpact keeps landing bigger, smarter deals today, future mix does not have to depend on filling capacity with lower-value work.

The deal quality looks meaningful. Genpact signed 12 large deals in the first half, at double last year's pace. Management also pointed to more than $1 billion in 2026 Agentic bookings. That suggests clients are not just buying short pilots; they are committing to larger programs that can become a steadier part of the business.

New clients strengthen the case

If only existing clients were spending more, the bull case would still have merit, but it would be narrower. The stronger signal is that more than half of cumulative Agentic contract value has come from new clients. That implies Genpact is not just extracting more from established relationships; it is winning new accounts and possibly new segments.

What investors should watch next

The setup is promising, but it remains a promise until execution shows up again. The near-term watchpoints are straightforward:

• Does backlog convert into revenue at a healthy pace?
• Do large deals stay large when they convert?
• Is the new-client mix holding up, or is growth becoming narrower?

There is also a known trade-off: Genpact is exiting small portions of lower-value content management and commoditized contact-center work, a move expected to weigh nearly two percentage points on 2026 revenue growth. Even so, management still expects at least 7% 2026 revenue growth and at least 12% adjusted diluted EPS growth. That is why the bull case remains interesting: the flywheel looks operational, but the market still wants proof that the newer work can offset the transition hit.

The bear case is about execution, not imagination

The multiple is not moving yet because a better mix is still only part of the story. The market will remain cautious if execution slips.

Higher targets give skeptics more to test

Bears are not really arguing that Genpact's transformation is fake. They are arguing that a better business model still has to beat the cycle. Management has raised the bar by guiding to at least 25% ATS growth and at least 12% adjusted diluted EPS growth. That helps the bull case, but it also gives skeptics a cleaner scoreboard. A premium multiple does not survive on ambition; it survives on repeated proof.

The clearest counterweight is the company's own transition hit. Genpact is exiting small portions of lower-value content management and commoditized contact-center work, and management said that will reduce 2026 revenue growth by nearly two percentage points. The impact is expected to be concentrated in the second half and may be larger in 2027. In plain English, the cleaner mix comes with a near-term speed bump. If revenue slows even a little, investors will want to see the higher-margin ATS business arriving fast enough to fill the gap.

What could break the premium

The next risk is not strategy. It is timing and macro friction:

• Conversion risk: strong bookings and backlog only matter if they turn into revenue and earnings on schedule.
• AI-budget cooling: if client spending slows, the market may stop treating Genpact as a higher-value operator and revert to a cyclical services valuation.
• Margin pressure: if the ATS shift slows, the company may not earn the right to trade at a richer multiple, even if quarter-to-quarter results still look decent.

Management still expects at least 7% 2026 net revenue growth and at least 12% adjusted diluted EPS growth. Bears will say those targets are only as strong as the next few quarters of proof.

What has to happen before year-end

Into year-end, the premium-multiple case comes down to a short scoreboard.

Confirmation signals

• ATS stays on target. Another quarter that keeps management's at least 25% ATS growth outlook within reach would suggest the mix shift is building, not fading.
• EPS still earns the premium. The next results should keep intact management's guide for at least 12% adjusted diluted EPS growth in 2026. If the higher-value mix is real, the earnings line should reflect it.
• Bookings turn into trustworthy numbers.Record quarterly bookings need to show up again as revenue conversion and margin progress, not just a fuller backlog.

Warning signals

• ATS looks strong, but the broader model does not. If strong ATS growth is paired with a miss against the at least 12% adjusted diluted EPS growth target, the market may assume the better mix has not reached critical mass.
• Demand momentum stalls. If record quarterly bookings are not repeated or do not convert cleanly, the premium case loses some of its forward fuel.

The practical takeaway into year-end is simple: stay constructive, but only on confirmation. Genpact looks more compelling if ATS progress, EPS guidance, and booking momentum keep validating each other.